Fred Alger Management’s Sierra Oncology, Inc. Common Stock SRRA Stock Holding History

Fred Alger Management’s Portfolio SRRA Stock Details SRRA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	–	Sell	-39,878	Closed	-$1.28M	–	567
2022 Q1	$1.28M	Buy	+39,878	New	+$1.14M	﹤0.01%	369
2019 Q2	–	Sell	-1,850	Closed	-$127K	–	572
2019 Q1	$127K	Hold	1,850	–	–	﹤0.01%	402
2018 Q4	$98K	Sell	1,850 -225	-11%	-$14.4K	﹤0.01%	385
2018 Q3	$141K	Hold	2,075	–	–	﹤0.01%	391
2018 Q2	$246K	Buy	+2,075	New	+$208K	﹤0.01%	383

Other funds holding SRRA

Vivo Capital Palo Alto, California $1.2B AUM 911.44% 1-Year Est. Return

Versor Investments New York $40.8M AUM 93.59% 1-Year Est. Return

Abingworth London, United Kingdom $307M AUM 93.47% 1-Year Est. Return

RSCM

Rock Springs Capital Management Baltimore, Maryland $1.7B AUM 93.03% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

TAL

TIG Advisors LLC New York $2.16B AUM 72.99% 1-Year Est. Return

FLSM

Frazier Life Sciences Management Palo Alto, California $3.89B AUM 201.1% 1-Year Est. Return

PBA

Paradigm Biocapital Advisors New York $4.89B AUM 251.12% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return

Fred Alger Management's SRRA Position: Q2 2022 in Review

Fred Alger Management sold out of Sierra Oncology, Inc. Common Stock (SRRA) in Q2 2022, closing a stake of 39,878 shares — an estimated $1.28M sold.

Fred Alger Management first reported a position in SRRA in Q2 2018 and held it in 5 quarters. The position peaked at $1.28M in Q1 2022. 109 funds tracked by Wall St. Rank hold SRRA as of Q2 2022.

Fred Alger Management reported no remaining Sierra Oncology, Inc. Common Stock position as of Q2 2022 after selling out during the quarter.
Fred Alger Management sold 39,878 Sierra Oncology, Inc. Common Stock shares in Q2 2022, an estimated $1.28M.
Fred Alger Management first reported a position in Sierra Oncology, Inc. Common Stock in Q2 2018 and held it in 5 quarters.
Fred Alger Management's Sierra Oncology, Inc. Common Stock position peaked at $1.28M in Q1 2022.
109 funds tracked by Wall St. Rank held Sierra Oncology, Inc. Common Stock as of Q2 2022.

Based on Fred Alger Management's 13F filing for Q2 2022, filed 15 Aug 2022.